Showing results (161-170 of 185) with videos related to
Sort By:
Pageof 19
Eclinicalmedicine|July 26, 2021
Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analysesManasi Agrawal, João Sabino, Catarina Frias-Gomes, et al.Inflammatory Bowel Diseases|November 9, 2025
Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic ReviewDavid T Rubin, Walter Reinisch, Neeraj Narula, et al.BMJ Open|November 9, 2024
Perspectives on the sustained engagement with digital health tools: protocol for a qualitative interview study among people living with Inflammatory Bowel Disease or irritable bowel syndromeJenny L Olson, Amelia Palumbo, Chloé Desjardins, et al.Journal of Crohn'S & Colitis|July 22, 2025
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel reviewSophie Vieujean, Bruce E Sands, Remo Panaccione, et al.BMJ Open Gastroenterology|February 15, 2022
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitisEdouard Louis, Kristine Paridaens, Sameer Al Awadhi, et al.Scandinavian Journal of Gastroenterology|December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitisAxel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.Journal of Crohn'S & Colitis|March 9, 2026
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel DiseaseAxel Dignass, Neeraj Narula, Krishan Pratap, et al.The American Journal of Gastroenterology|December 29, 2022
REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort StudyChristopher Ma, Remo Panaccione, Yasi Xiao, et al.The American Journal of Gastroenterology|November 12, 2024
Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's DiseaseDina Kao, Karen Wong, Humberto Jijon, et al.The American Journal of Gastroenterology|May 9, 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule InhibitorsParambir S Dulai, Robert Battat, Maria Barsky, et al.Pageof 19